TCAF2 and prostate carcinoma: Prior research on prostate cancer has unearthed parallel findings, where TCAF2’s interaction with TRPM8 facilitates its cell surface transport and suppresses its ion channel activity, effectively enhancing the migration of prostate cancer cells in vitro [14,70].